Skip to main content

Paul M. Schoenhard Quoted in Bloomberg Law

Media mentions | November 9, 2022

Bloomberg Law quoted partner Paul M. Schoenhard on the potential impacts of a US Supreme Court decision in Amgen Inc. v. Sanofi, which turns on interpretation of the patent “enablement” standard, for the pharmaceutical industry and beyond.

Click here to read the article (subscription required).

This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.